Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bennett, M
Right arrow Articles by Schechter, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bennett, M
Right arrow Articles by Schechter, G.
Haematologica, Vol 90, Issue 6, 856-858
Copyright © 2005 by Ferrata Storti Foundation

Letter

Rituximab monotherapy for splenic marginal zone lymphoma

M Bennett, K Sharma, S Yegena, I Gavish, HP Dave, and GP Schechter

In this retrospective study, rituximab was found to be effective therapy in 10 of 11 patients with splenic marginal zone lymphoma, inducing prompt reduction in splenomegaly, improvement in blood counts in 9 patients and clearance of a pleural effusion in 1 patient. Median response duration was 21 months (range 4 to 37 months). Two patients who relapsed at 21 and 23 months responded to retreatment. Rituximab should be considered in patients who are poor candidates for splenectomy.


This article has been cited by other articles:


Home page
 NEJMHome page
J. S. Abramson, M. Chatterji, and A. Rahemtullah
Case 39-2008 -- A 51-Year-Old Woman with Splenomegaly and Anemia
N. Engl. J. Med., December 18, 2008; 359(25): 2707 - 2718.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Meyer zum Buschenfelde, Y. Feuerstacke, K. S. Gotze, K. Scholze, and C. Peschel
GM1 Expression of Non-Hodgkin's Lymphoma Determines Susceptibility to Rituximab Treatment
Cancer Res., July 1, 2008; 68(13): 5414 - 5422.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2005 by the Ferrata Storti Foundation.